Zhao J - Search Results

1

Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review.

Zhang X, Han H, Zhao J, Liu X, Zhang J, Sun R, Li S, Liu B, Zhu H, Jiao S, Li X, Tang H. Zhang X, et al. Among authors: zhao j. Front Pharmacol. 2022 Aug 17;13:964606. doi: 10.3389/fphar.2022.964606. eCollection 2022. Front Pharmacol. 2022. PMID: 36059942 Free PMC article.

2

A Case of Novel Inversion Mutation of EGFR Exon 19 Leading to Primary Resistance to EGFR TKIs in Lung Adenocarcinoma.

Li S, Zhao J, Wang Q. Li S, et al. Among authors: zhao j. J Thorac Oncol. 2018 Jun;13(6):e97-e101. doi: 10.1016/j.jtho.2017.12.014. Epub 2018 Feb 28. J Thorac Oncol. 2018. PMID: 29501421 Free article. No abstract available.

3

PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review.

Yang L, Wu Y, Tang H, Zhao J, Zhao D, Yang S, Wang Q. Yang L, et al. Among authors: zhao j, zhao d. Onco Targets Ther. 2018 Apr 5;11:1921-1927. doi: 10.2147/OTT.S155033. eCollection 2018. Onco Targets Ther. 2018. PMID: 29670367 Free PMC article.

4

Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.

Yang K, Li J, Zhao J, Ren P, Wang Z, Wei B, Dong B, Sun R, Wang X, Groen HJM, Ma J, Guo Y. Yang K, et al. Among authors: zhao j. Anal Chem. 2018 Oct 2;90(19):11203-11209. doi: 10.1021/acs.analchem.8b01776. Epub 2018 Sep 11. Anal Chem. 2018. PMID: 30156405

5

Combined plasma and tissue genotyping of EGFR T790M benefits NSCLC patients: a real-world clinical example.

Wei B, Zhao C, Li J, Zhao J, Ren P, Yang K, Yan C, Sun R, Ma J, Guo Y. Wei B, et al. Among authors: zhao j, zhao c. Mol Oncol. 2019 May;13(5):1226-1234. doi: 10.1002/1878-0261.12481. Epub 2019 Apr 10. Mol Oncol. 2019. PMID: 30927306 Free PMC article. Clinical Trial.

6

Clinicopathologic characteristics and diagnostic methods of RET rearrangement in Chinese non-small cell lung cancer patients.

Feng J, Li Y, Wei B, Guo L, Li W, Xia Q, Zhao C, Zheng J, Zhao J, Sun R, Guo Y, Brcic L, Hakozaki T, Ying J, Ma J. Feng J, et al. Among authors: zhao j, zhao c. Transl Lung Cancer Res. 2022 Apr;11(4):617-631. doi: 10.21037/tlcr-22-202. Transl Lung Cancer Res. 2022. PMID: 35529790 Free PMC article.

7

Case report: sequential use of almonertinib based on the EGFR exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients.

Wang R, Yu S, Yu L, Zhao J, Jiao S, Wang Q, Wu Y. Wang R, et al. Among authors: zhao j. Transl Cancer Res. 2022 Jun;11(6):1836-1843. doi: 10.21037/tcr-21-2728. Transl Cancer Res. 2022. PMID: 35836508 Free PMC article.

8

Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report.

Zhao J, Li X, Fan R, Qin Y, Wang Z, Wang B, Li S, Fan J, Wu X, Liu H, Guan Y, Liang Y, Zhang X, Guo Y. Zhao J, et al. Front Pharmacol. 2022 Nov 23;13:1060460. doi: 10.3389/fphar.2022.1060460. eCollection 2022. Front Pharmacol. 2022. PMID: 36506539 Free PMC article.

9

Effects of p450 Polymorphisms on the Clinical Outcomes of Gefitinib Treatment in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer.

Fan R, Zhao J, Wang B, Li X, Guan Y, Ren P, Sun R, Zhang L, Guo Y. Fan R, et al. Among authors: zhao j. Genet Test Mol Biomarkers. 2022 Dec;26(12):582-588. doi: 10.1089/gtmb.2022.0070. Genet Test Mol Biomarkers. 2022. PMID: 36577124

10

Development and clinical applications of an enclosed automated targeted NGS library preparation system.

Shi C, Feng Y, Sun R, Chen J, Zhao Y, Wang Z, Xie S, Zhou J, Yang L, Cao X, Feng J, Zhang C, Wei B, Wang X, Chang Y, Zhao J, Wang Z, Zheng J, Liu J, Chantratita W, Xiong L, Zhang D, Chen C, Ma J. Shi C, et al. Among authors: zhao j, zhao y. Clin Chim Acta. 2023 Feb 1;540:117224. doi: 10.1016/j.cca.2023.117224. Epub 2023 Jan 7. Clin Chim Acta. 2023. PMID: 36627008 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56,468 results

Search Page

Filters